Appropriate Dosing of Toradol 10mg for Severe Pain and Naproxen for Moderate Pain
For severe pain, Toradol (ketorolac) 10mg should be given orally every 4-6 hours as needed, not exceeding 40mg daily, and limited to a maximum of 5 days of use. For moderate pain, naproxen sodium 275-550mg should be administered every 2-6 hours, with a maximum initial dose of 825mg and not exceeding 1.5g daily. 1, 2
Toradol (Ketorolac) Dosing for Severe Pain
Dosage and Administration
- Toradol oral therapy should only be used as continuation therapy following IV or IM dosing, not as initial therapy 1
- For adults 17-64 years: 20mg PO once, followed by 10mg every 4-6 hours as needed, not exceeding 40mg/day 1
- For adults ≥65 years, renally impaired patients, or those weighing <50kg: 10mg PO once, followed by 10mg every 4-6 hours as needed, not exceeding 40mg/day 1
- Use the lowest effective dose for the shortest duration consistent with treatment goals 1
Duration Limitations
- Total duration of treatment must not exceed 5 days (combined IV/IM and oral use) 1, 3
- Patients should be switched to alternative analgesics as soon as possible 1
Contraindications and Precautions
- Do not use in patients with history of:
- Do not use concurrently with other NSAIDs 3
Common Adverse Effects
- Edema, drowsiness, dizziness, GI upset, increased diaphoresis 2
- Risk of GI bleeding increases markedly when used at high doses for more than 5 days, especially in elderly patients 4
Naproxen Dosing for Moderate Pain
Dosage and Administration
- Standard dosage: 275-550mg every 2-6 hours 2
- Maximum initial dose: 825mg 2
- Maximum daily dose: Do not exceed 1.5g per day 2, 5
- For prescription naproxen: 375-500mg twice daily (every 12 hours) is recommended 5
- For over-the-counter naproxen sodium (Aleve): 440mg (2 tablets of 220mg) twice daily 5
Duration of Treatment
- Initial treatment should be for 2-4 weeks at maximum tolerated and approved dosage 5
- Evaluate treatment response after 2-4 weeks 5
- If sufficient response is achieved, treatment can be continued with consideration for tapering after 12 weeks of sustained response 5
Contraindications and Precautions
- Do not use in patients with:
Common Adverse Effects
- Dizziness, rash, pruritus, GI upset, constipation 2
- Dyspepsia and GI discomfort occur in 10-20% of patients 5
Clinical Pearls
- For both medications, use the lowest effective dose for the shortest duration to minimize adverse effects 1, 5
- Consider gastroprotection with a proton pump inhibitor or H2 blocker in high-risk patients taking either medication 5
- Monitor for signs of GI bleeding, especially in elderly patients or those on prolonged therapy 5, 4
- Ketorolac has been shown to provide similar analgesic efficacy to opioids like morphine in postoperative settings, making it a valuable non-opioid alternative for severe pain 6, 4
- Combined therapy with ketorolac and an opioid can result in a 25-50% reduction in opioid requirements, potentially reducing opioid-related adverse events 4